2023 Q3 Form 10-Q Financial Statement

#000090616323000108 Filed on August 02, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $2.569B $2.378B
YoY Change -7.98% -10.58%
Cost Of Revenue $1.902B $1.728B
YoY Change -9.09% -10.21%
Gross Profit $713.0M $649.4M
YoY Change 1.95% -12.51%
Gross Profit Margin 27.75% 27.31%
Selling, General & Admin $166.8M $171.4M
YoY Change 8.55% 9.93%
% of Gross Profit 23.39% 26.39%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $4.200M $4.217M
YoY Change -1.08% -6.93%
% of Gross Profit 0.59% 0.65%
Operating Expenses $166.7M $171.4M
YoY Change 8.48% 9.93%
Operating Profit $546.3M $478.0M
YoY Change 0.11% -18.47%
Interest Expense -$6.900M -$6.795M
YoY Change -4.19% -155.44%
% of Operating Profit -1.26% -1.42%
Other Income/Expense, Net
YoY Change
Pretax Income $539.3M $471.2M
YoY Change 0.15% -17.92%
Income Tax $106.2M $67.15M
% Of Pretax Income 19.69% 14.25%
Net Earnings $433.2M $404.0M
YoY Change 5.29% -6.76%
Net Earnings / Revenue 16.86% 16.99%
Basic Earnings Per Share $132.90 $123.80
Diluted Earnings Per Share $125.30 $116.50
COMMON SHARES
Basic Shares Outstanding 3.264M shares 3.263M shares
Diluted Shares Outstanding 3.458M shares 3.467M shares

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.909B $2.693B
YoY Change 64.63% 79.55%
Cash & Equivalents $2.970B $2.693B
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory $2.004B $2.020B
Prepaid Expenses
Receivables $33.90M $26.76M
Other Receivables $0.00 $0.00
Total Short-Term Assets $4.947B $4.739B
YoY Change 24.73% 21.3%
LONG-TERM ASSETS
Property, Plant & Equipment $161.9M $158.7M
YoY Change 12.67% 11.43%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $28.10M $27.60M
YoY Change 1.08% -8.0%
Other Assets $61.10M $65.47M
YoY Change 12.81% 1.74%
Total Long-Term Assets $1.426B $1.527B
YoY Change 0.13% 10.65%
TOTAL ASSETS
Total Short-Term Assets $4.947B $4.739B
Total Long-Term Assets $1.426B $1.527B
Total Assets $6.372B $6.267B
YoY Change 18.23% 18.52%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $440.6M $436.2M
YoY Change -11.18% -6.32%
Accrued Expenses $490.2M $394.6M
YoY Change -5.21% -17.02%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.286B $1.200B
YoY Change -7.43% -13.09%
LONG-TERM LIABILITIES
Long-Term Debt $913.5M $914.0M
YoY Change -0.2% -0.2%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $913.5M $914.0M
YoY Change -0.2% -0.2%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.286B $1.200B
Total Long-Term Liabilities $913.5M $914.0M
Total Liabilities $2.200B $2.114B
YoY Change -4.56% -7.95%
SHAREHOLDERS EQUITY
Retained Earnings $12.95B $12.52B
YoY Change 14.46% 14.8%
Common Stock $2.801B $2.748B
YoY Change 10.33% 9.99%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $4.173B $4.153B
YoY Change
Total Liabilities & Shareholders Equity $6.372B $6.267B
YoY Change 18.23% 18.52%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income $433.2M $404.0M
YoY Change 5.29% -6.76%
Depreciation, Depletion And Amortization $4.200M $4.217M
YoY Change -1.08% -6.93%
Cash From Operating Activities $658.1M $28.68M
YoY Change 8.65% -79.2%
INVESTING ACTIVITIES
Capital Expenditures $7.100M $8.734M
YoY Change -320.43% -286.03%
Acquisitions
YoY Change
Other Investing Activities $200.0K $1.196M
YoY Change -3.38% -113.88%
Cash From Investing Activities -$6.900M -$7.538M
YoY Change 128.93% -43.36%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net -$121.3M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -439.3M -121.7M
YoY Change 27.23% -84.55%
NET CHANGE
Cash From Operating Activities 658.1M 28.68M
Cash From Investing Activities -6.900M -7.538M
Cash From Financing Activities -439.3M -121.7M
Net Change In Cash 211.9M -100.5M
YoY Change -17.68% -84.84%
FREE CASH FLOW
Cash From Operating Activities $658.1M $28.68M
Capital Expenditures $7.100M $8.734M
Free Cash Flow $651.0M $19.95M
YoY Change 6.91% -86.01%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 nvr Number Of Finished Lots Expected To Be Developed From Raw Parcels Of Land
NumberOfFinishedLotsExpectedToBeDevelopedFromRawParcelsOfLand
1600 lot
CY2023Q2 nvr Aggregate Additional Funding Commitments Related To Raw Land Property Development
AggregateAdditionalFundingCommitmentsRelatedToRawLandPropertyDevelopment
1900000 usd
CY2023Q2 nvr Expected Development Credit
ExpectedDevelopmentCredit
900000 usd
CY2022Q4 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
570000 usd
CY2021Q4 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
593000 usd
us-gaap Interest Costs Incurred
InterestCostsIncurred
13826000 usd
us-gaap Interest Costs Incurred
InterestCostsIncurred
25603000 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
6795000 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
12257000 usd
us-gaap Interest Expense
InterestExpense
14053000 usd
us-gaap Interest Expense
InterestExpense
25423000 usd
us-gaap Real Estate Inventory Capitalized Interest Costs Cost Of Sales1
RealEstateInventoryCapitalizedInterestCostsCostOfSales1
154000 usd
us-gaap Real Estate Inventory Capitalized Interest Costs Cost Of Sales1
RealEstateInventoryCapitalizedInterestCostsCostOfSales1
93000 usd
CY2023Q2 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
189000 usd
CY2022Q2 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
680000 usd
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3250960 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3335644 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
205446 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
244445 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3456406 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3580089 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
175338 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
189988 shares
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
3845346000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
404027000 usd
CY2023Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
201077000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
25159000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
79808000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
4153263000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
3506849000 usd
us-gaap Net Income Loss
NetIncomeLoss
748379000 usd
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
311125000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
47436000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
161724000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
4153263000 usd
CY2023Q2 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
34827 shares
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
56001 shares
CY2023Q2 nvr Stock Issued During Period Shares Treasury Stock Reissued Upon Exercise Of Stock Option And Other
StockIssuedDuringPeriodSharesTreasuryStockReissuedUponExerciseOfStockOptionAndOther
53615 shares
nvr Stock Issued During Period Shares Treasury Stock Reissued Upon Exercise Of Stock Option And Other
StockIssuedDuringPeriodSharesTreasuryStockReissuedUponExerciseOfStockOptionAndOther
97556 shares
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
2725599000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
433314000 usd
CY2022Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
266915000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
20087000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
79581000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
2991666000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
3002378000 usd
us-gaap Net Income Loss
NetIncomeLoss
859414000 usd
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
1015703000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
31755000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
113822000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
2991666000 usd
CY2022Q2 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
61078 shares
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
207132 shares
CY2022Q2 nvr Stock Issued During Period Shares Treasury Stock Reissued Upon Exercise Of Stock Option And Other
StockIssuedDuringPeriodSharesTreasuryStockReissuedUponExerciseOfStockOptionAndOther
30396 shares
nvr Stock Issued During Period Shares Treasury Stock Reissued Upon Exercise Of Stock Option And Other
StockIssuedDuringPeriodSharesTreasuryStockReissuedUponExerciseOfStockOptionAndOther
43719 shares
CY2022Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
144006000 usd
CY2021Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
134859000 usd
nvr Costs Accrued For New Warranty Contracts And Changes In Estimates For Pre Existing Warranties
CostsAccruedForNewWarrantyContractsAndChangesInEstimatesForPreExistingWarranties
43582000 usd
nvr Costs Accrued For New Warranty Contracts And Changes In Estimates For Pre Existing Warranties
CostsAccruedForNewWarrantyContractsAndChangesInEstimatesForPreExistingWarranties
42518000 usd
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
45168000 usd
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
39137000 usd
CY2023Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
142420000 usd
CY2022Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
138240000 usd
us-gaap Revenues
Revenues
4516607000 usd
us-gaap Revenues
Revenues
5037352000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
904986000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
1139957000 usd
CY2023Q2 us-gaap Assets
Assets
6266775000 usd
CY2022Q4 us-gaap Assets
Assets
5660973000 usd
nvr Fair Value Measurement Assumed Gain Loss From Loan Sale
FairValueMeasurementAssumedGainLossFromLoanSale
10686000 usd
nvr Fair Value Measurements Interest Rate Movement Effect
FairValueMeasurementsInterestRateMovementEffect
-29700000 usd
nvr Fair Value Measurements Changes In Servicing Rights Value
FairValueMeasurementsChangesInServicingRightsValue
40949000 usd
nvr Fair Value Measurements Security Price Change Gain Loss Included In Earnings
FairValueMeasurementsSecurityPriceChangeGainLossIncludedInEarnings
13119000 usd
us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
35054000 usd
CY2022 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
-7435000 usd
CY2023Q2 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
13231000 usd
CY2023Q2 us-gaap Finance Lease Liability
FinanceLeaseLiability
14690000 usd
CY2022Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
13745000 usd
CY2022Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
15002000 usd
CY2023Q2 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P17Y2M12D
us-gaap Lessee Operating Lease Option To Extend
LesseeOperatingLeaseOptionToExtend
20
CY2023Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
9475000 usd
CY2022Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
8529000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
18615000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
16630000 usd
CY2022Q2 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
473000 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
1013000 usd
CY2022Q2 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
103000 usd
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
211000 usd
CY2022Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
6491000 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
15023000 usd
CY2022Q2 us-gaap Lease Cost
LeaseCost
15596000 usd
us-gaap Lease Cost
LeaseCost
34862000 usd
CY2022Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
6935000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
14736000 usd
CY2022Q2 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
103000 usd
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
211000 usd
CY2022Q2 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
367000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
811000 usd
CY2022Q2 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
18073000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
23337000 usd
CY2022Q2 us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
451000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
499000 usd
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y10M24D
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y
CY2023Q2 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P10Y4M24D
CY2022Q4 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P10Y9M18D
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.040
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.036
CY2023Q2 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.030
CY2022Q4 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.029
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.173
CY2022Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.245
nvr Adjustment To Income Tax Expense Income Tax Effect From Share Based Compensation Net
AdjustmentToIncomeTaxExpenseIncomeTaxEffectFromShareBasedCompensationNet
79151000 usd
CY2022Q2 nvr Adjustment To Income Tax Expense Income Tax Effect From Share Based Compensation Net
AdjustmentToIncomeTaxExpenseIncomeTaxEffectFromShareBasedCompensationNet
8744000 usd

Files In Submission

Name View Source Status
0000906163-23-000108-index-headers.html Edgar Link pending
0000906163-23-000108-index.html Edgar Link pending
0000906163-23-000108.txt Edgar Link pending
0000906163-23-000108-xbrl.zip Edgar Link pending
exhibit101.htm Edgar Link pending
exhibit311q22023.htm Edgar Link pending
exhibit312q22023.htm Edgar Link pending
exhibit32q22023.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
nvr-20230630.htm Edgar Link pending
nvr-20230630.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
nvr-20230630_cal.xml Edgar Link unprocessable
nvr-20230630_def.xml Edgar Link unprocessable
nvr-20230630_lab.xml Edgar Link unprocessable
nvr-20230630_pre.xml Edgar Link unprocessable
nvr-20230630_htm.xml Edgar Link completed
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable